Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
NUVB.WS
22 hedge funds and large institutions have $4.11M invested in Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SB
1
Samsara BioCapital
Palo Alto,
California
|
$37K |
| 2 |
ACP
2
Acuta Capital Partners
Redwood City,
California
|
$25K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$1K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$21K |
Top Sellers
| 1 |
HCM
1
Highbridge Capital Management
New York
|
$110K |
| 2 |
2
Walleye Capital
New York
|
$22K |
| 3 |
IP
3
Intellectus Partners
San Francisco,
California
|
$6K |
